Turn Therapeutics, Inc. (TTRX)
9.63
+0.17
(+1.80%)
USD |
NASDAQ |
Aug 24, 16:00
9.68
+0.05
(+0.52%)
After-Hours: 20:00
Turn Therapeutics Enterprise Value : 277.63M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 277.63M |
| August 20, 2026 | 280.01M |
| August 19, 2026 | 288.35M |
| August 18, 2026 | 293.41M |
| August 17, 2026 | 291.03M |
| August 14, 2026 | 280.90M |
| August 13, 2026 | 289.54M |
| August 12, 2026 | 309.80M |
| August 11, 2026 | 300.27M |
| August 10, 2026 | 281.80M |
| August 07, 2026 | 305.93M |
| August 06, 2026 | 282.10M |
| August 05, 2026 | 276.73M |
| August 04, 2026 | 279.41M |
| August 03, 2026 | 259.16M |
| July 31, 2026 | 244.86M |
| July 30, 2026 | 241.58M |
| July 29, 2026 | 217.16M |
| July 28, 2026 | 225.20M |
| July 27, 2026 | 227.58M |
| July 24, 2026 | 250.22M |
| July 23, 2026 | 278.22M |
| July 22, 2026 | 282.39M |
| July 21, 2026 | 299.07M |
| July 20, 2026 | 295.20M |
| Date | Value |
|---|---|
| July 17, 2026 | 267.50M |
| July 16, 2026 | 264.82M |
| July 15, 2026 | 281.20M |
| July 14, 2026 | 282.99M |
| July 13, 2026 | 277.92M |
| July 10, 2026 | 277.03M |
| July 09, 2026 | 258.26M |
| July 08, 2026 | 269.58M |
| July 07, 2026 | 285.07M |
| July 06, 2026 | 224.90M |
| July 02, 2026 | 207.92M |
| July 01, 2026 | 199.88M |
| June 30, 2026 | 213.28M |
| June 29, 2026 | 200.62M |
| June 26, 2026 | 201.22M |
| June 25, 2026 | 197.94M |
| June 24, 2026 | 176.20M |
| June 23, 2026 | 173.22M |
| June 22, 2026 | 166.66M |
| June 18, 2026 | 169.64M |
| June 17, 2026 | 174.41M |
| June 16, 2026 | 178.28M |
| June 15, 2026 | 186.03M |
| June 12, 2026 | 174.86M |
| June 11, 2026 | 169.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.966B |
| Corcept Therapeutics, Inc. | 12.89B |
| Veru, Inc. | 21.90M |
| Johnson & Johnson | 679.08B |
| Eli Lilly & Co. | 1.228T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.850M |
| Total Expenses (Quarterly) | 5.850M |
| EPS Diluted (Quarterly) | -0.1964 |
| Earnings Yield | -2.99% |
| Normalized Earnings Yield | -3.075 |